These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Improving availability and affordability of plasma-derived medicines. Cheraghali AM; Abolghasemi H Biologicals; 2010 Jan; 38(1):81-6. PubMed ID: 20137973 [TBL] [Abstract][Full Text] [Related]
7. Plasma-derived medicinal products self-sufficiency from national plasma: to what extent? De Angelis V; Breda A Blood Transfus; 2013 Sep; 11 Suppl 4(Suppl 4):s132-7. PubMed ID: 24333306 [No Abstract] [Full Text] [Related]
8. The evolution of the regulatory framework for the plasma and plasma-derived medicinal products system in Italy. Calizzani G; Vaglio S; Candura F; Profili S; Lanzoni M; Cristiano K; Tamburrini MR; Grazzini G; Oleari F Blood Transfus; 2013 Sep; 11 Suppl 4(Suppl 4):s6-12. PubMed ID: 24333315 [No Abstract] [Full Text] [Related]
9. Drug concentrations in plasma. Marschner JP Int J Clin Pharmacol Ther; 1994 Jun; 32(6):321. PubMed ID: 7921535 [No Abstract] [Full Text] [Related]
10. Plasma-derived medicinal products in Italy: information sources and flows. Lanzoni M; Biffoli C; Candura F; Calizzani G; Vaglio S; Grazzini G Blood Transfus; 2013 Sep; 11 Suppl 4(Suppl 4):s13-7. PubMed ID: 24333305 [No Abstract] [Full Text] [Related]
11. Potential metal impurities in active pharmaceutical substances and finished medicinal products - A market surveillance study. Wollein U; Bauer B; Habernegg R; Schramek N Eur J Pharm Sci; 2015 Sep; 77():100-5. PubMed ID: 26036232 [TBL] [Abstract][Full Text] [Related]
12. Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulations. Khalil IF; Alifrangis M; Recke C; Hoegberg LC; Ronn A; Bygbjerg IC; Koch C Malar J; 2011 Aug; 10():249. PubMed ID: 21864375 [TBL] [Abstract][Full Text] [Related]
13. Timing of analog research in medicinal chemistry. Fischer J; Gere A Pharmazie; 2001 Sep; 56(9):675-82. PubMed ID: 11593984 [TBL] [Abstract][Full Text] [Related]
14. The Dublin Consensus Statement 2012 on optimised supply of plasma-derived medicinal products. O'Mahony B Blood Transfus; 2013 Oct; 11(4):623-6. PubMed ID: 24120590 [No Abstract] [Full Text] [Related]
15. Strategies and Tactics in Medicinal Chemistry. Manssour Fraga CA Curr Top Med Chem; 2019; 19(19):1677-1678. PubMed ID: 31659943 [No Abstract] [Full Text] [Related]
16. An integrated ceramic, micro-fluidic device for the LC/MS/MS analysis of pharmaceuticals in plasma. Rainville PD; Murphy JP; Tomany M; Wilson ID; Smith NW; Evans C; Kheler J; Bowen C; Plumb RS; Nicholson JK Analyst; 2015 Aug; 140(16):5546-56. PubMed ID: 26146891 [TBL] [Abstract][Full Text] [Related]
17. Sustainability of a public system for plasma collection, contract fractionation and plasma-derived medicinal product manufacturing. Grazzini G; Ceccarelli A; Calteri D; Catalano L; Calizzani G; Cicchetti A Blood Transfus; 2013 Sep; 11 Suppl 4(Suppl 4):s138-47. PubMed ID: 24333307 [TBL] [Abstract][Full Text] [Related]
18. Botanicals: Innovative Tools for Pharmaceutical, Cosmetic and Nutraceutical. Puglia C; Lauro MR Curr Med Chem; 2019; 26(24):4504-4505. PubMed ID: 31654565 [No Abstract] [Full Text] [Related]
19. Medicinal chemistry: Exploring the third dimension. Kingwell K Nat Rev Drug Discov; 2009 Dec; 8(12):931. PubMed ID: 19967797 [No Abstract] [Full Text] [Related]
20. Yin and Yang in medicinal chemistry: what does drug-likeness mean? Macarrón R; Luengo JI Future Med Chem; 2011 Apr; 3(5):505-7. PubMed ID: 21526891 [No Abstract] [Full Text] [Related] [Next] [New Search]